Literature DB >> 11042347

Phorbol ester synergistically increases interferon regulatory factor-1 and inducible nitric oxide synthase induction in interferon-gamma-treated RAW 264.7 cells.

I Momose1, M Terashima, Y Nakashima, M Sakamoto, H Ishino, T Nabika, Y Hosokawa, Y Tanigawa.   

Abstract

The roles of PKC in iNOS induction by IFN-gamma have been shown in some cell types. The effect of a PKC activator, phorbol ester, in iNOS induction is thought to be due to multiple mechanisms, and it is necessary to examine the involvement of phorbol ester on IFN-gamma-induced iNOS in detail. In the present study, we investigated the mechanisms of phorbol ester on IFN-gamma-induced iNOS in RAW 264.7 cells. PMA synergistically increased iNOS activity, protein and mRNA levels in IFN-gamma-treated RAW 264.7 cells. PMA together with IFN-gamma increased iNOS mRNA without affecting the iNOS mRNA degradation, suggesting that the synergistic effect of PMA on IFN-gamma-induced iNOS mRNA production may depend on the elevation of the transcription rate rather than a prolongation of mRNA stability. The DNA binding proteins that are involved in the regulation of iNOS expression are mainly NF-kappa B and IRF-1. IRF-1 transcriptionally regulates many IFN-inducible genes such as iNOS whose promoter contains an IRF-1 binding site. PMA might modulate iNOS induction as a cosignal with IFN-gamma in RAW 264.7 cells because the synergistic effect of PMA was mediated through IRF-1, rather than NF-kappa B. Ro 31-8220, a PKC inhibitor, decreased iNOS activity, protein, mRNA levels and IRF-1 activity, indicating that the effect of PMA on iNOS induction might occur via the PKC pathway. It is evidence that PKC plays an important role in IRF-1 activation and that phorbol ester has a synergistic effect on iNOS induction through IRF-1 activation in IFN-gamma-treated RAW 264.7 cells. The synergistic effect of PMA on IFN-gamma-induced IRF-1 binding activity was observed in macrophage cell line J774 cells as well as RAW 264.7 cells, but not in thioglycollate-elicited peritoneal macrophages.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11042347     DOI: 10.1016/s0167-4889(00)00072-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  The role of interleukin-12 on modulating myeloid-derived suppressor cells, increasing overall survival and reducing metastasis.

Authors:  Catherine E Steding; Sung-tse Wu; Yanping Zhang; Meei-Huey Jeng; Bennett D Elzey; Chinghai Kao
Journal:  Immunology       Date:  2011-04-01       Impact factor: 7.397

2.  In vivo evidence for a role of protein kinase C in peripheral nociceptive processing.

Authors:  Adriano L S Souza; Fabrício A Moreira; Karine R Almeida; Caryne M Bertollo; Karina A Costa; Márcio M Coelho
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

3.  Evaluation of iNOS Expression in Esophageal Cancer Patients.

Authors:  Romina Barani; Gholamreza Motalleb; Hossein Maghsoudi
Journal:  Gastrointest Tumors       Date:  2016-03-17

4.  Ginsenoside Rg3 inhibits phenylephrine-induced vascular contraction through induction of nitric oxide synthase.

Authors:  Nak Doo Kim; Eun Mi Kim; Keon Wook Kang; Min Kyung Cho; So Yeon Choi; Sang Geon Kim
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

5.  Carnosine Protects Macrophages against the Toxicity of Aβ1-42 Oligomers by Decreasing Oxidative Stress.

Authors:  Giuseppe Caruso; Cristina Benatti; Nicolò Musso; Claudia G Fresta; Annamaria Fidilio; Giorgia Spampinato; Nicoletta Brunello; Claudio Bucolo; Filippo Drago; Susan M Lunte; Blake R Peterson; Fabio Tascedda; Filippo Caraci
Journal:  Biomedicines       Date:  2021-04-26

6.  Carnosine Decreases PMA-Induced Oxidative Stress and Inflammation in Murine Macrophages.

Authors:  Giuseppe Caruso; Claudia G Fresta; Annamaria Fidilio; Fergal O'Donnell; Nicolò Musso; Giacomo Lazzarino; Margherita Grasso; Angela M Amorini; Fabio Tascedda; Claudio Bucolo; Filippo Drago; Barbara Tavazzi; Giuseppe Lazzarino; Susan M Lunte; Filippo Caraci
Journal:  Antioxidants (Basel)       Date:  2019-08-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.